Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.

Yoo F, Kuan EC, Heaney AP, Bergsneider M, Wang MB.

Pituitary. 2018 Feb 5. doi: 10.1007/s11102-018-0872-8. [Epub ahead of print] Review.

PMID:
29404894
2.

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O'Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR.

J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12. No abstract available.

PMID:
29025982
3.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.

Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, Kunz PL, O'Dorisio TM, Salem R, Segelov E, Howe JR, Pommier RF, Brendtro K, Bashir MA, Singh S, Soulen MC, Tang L, Zacks JS, Yao JC, Bergsland EK.

Pancreas. 2017 Jul;46(6):707-714. doi: 10.1097/MPA.0000000000000850. Review.

PMID:
28609356
4.

Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.

Calais J, Czernin J, Eiber M, Fendler WP, Gartmann J, Heaney AP, Hendifar AE, Pisegna JR, Hecht JR, Wolin EM, Slavik R, Gupta P, Quon A, Schiepers C, Allen-Auerbach MS, Herrmann K.

J Nucl Med. 2017 Nov;58(11):1793-1796. doi: 10.2967/jnumed.117.192450. Epub 2017 May 4.

5.

False responses of Renilla luciferase reporter control to nuclear receptor TR4.

Zhang D, Atlasi SS, Patel KK, Zhuang Z, Heaney AP.

Mol Cell Biochem. 2017 Jun;430(1-2):139-147. doi: 10.1007/s11010-017-2961-9. Epub 2017 Feb 16.

PMID:
28210900
6.

Targeting the ERK pathway for the treatment of Cushing's disease.

Zhang D, Bergsneider M, Wang MB, Heaney AP.

Oncotarget. 2016 Oct 25;7(43):69149-69158. doi: 10.18632/oncotarget.12381.

7.

Molecular markers in pituitary tumors.

Robertson AM, Heaney AP.

Curr Opin Endocrinol Diabetes Obes. 2016 Aug;23(4):324-30. doi: 10.1097/MED.0000000000000266. Review.

PMID:
27254269
8.

Testicular Receptor-4: Novel Regulator of Glucocorticoid Resistance.

Zhang D, Du L, Heaney AP.

J Clin Endocrinol Metab. 2016 Aug;101(8):3123-33. doi: 10.1210/jc.2016-1379. Epub 2016 Jun 2.

PMID:
27253665
9.

Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.

Yuen KC, Heaney AP, Popovic V.

Endocrine. 2016 May;52(2):194-205. doi: 10.1007/s12020-015-0840-2. Epub 2016 Jan 5. Review.

PMID:
26732039
10.

HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis.

Heaney AP, Sumerel B, Rajalingam R, Bergsneider M, Yong WH, Liau LM.

J Clin Endocrinol Metab. 2015 Nov;100(11):4092-7. doi: 10.1210/jc.2015-2702. Epub 2015 Aug 28.

PMID:
26317559
11.

Assessing the cost of contemporary pituitary care.

McLaughlin N, Martin NA, Upadhyaya P, Bari AA, Buxey F, Wang MB, Heaney AP, Bergsneider M.

Neurosurg Focus. 2014 Nov;37(5):E7. doi: 10.3171/2014.8.FOCUS14445.

PMID:
26223274
12.

Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients.

Javorsky BR, Carroll TB, Tritos NA, Salvatori R, Heaney AP, Fleseriu M, Biller BM, Findling JW.

Obes Surg. 2015 Dec;25(12):2306-13. doi: 10.1007/s11695-015-1681-z.

PMID:
25917980
13.

Editorial: pituitary tumors.

Bergsneider M, Heaney AP, Lee JY.

J Neurooncol. 2014 May;117(3):377-8. doi: 10.1007/s11060-014-1426-1. No abstract available.

PMID:
24733644
14.

The pituitary stalk effect: is it a passing phenomenon?

Bergsneider M, Mirsadraei L, Yong WH, Salamon N, Linetsky M, Wang MB, McArthur DL, Heaney AP.

J Neurooncol. 2014 May;117(3):477-84. doi: 10.1007/s11060-014-1386-5. Epub 2014 Feb 19.

PMID:
24549751
15.

Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.

Du L, Bergsneider M, Mirsadraei L, Young SH, Jonker JW, Downes M, Yong WH, Evans RM, Heaney AP.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8555-60. doi: 10.1073/pnas.1306182110. Epub 2013 May 7.

16.

Regulation of adipose differentiation by fructose and GluT5.

Du L, Heaney AP.

Mol Endocrinol. 2012 Oct;26(10):1773-82. Epub 2012 Jul 24.

17.

Pituitary function in patients with normal pressure hydrocephalus before and after neurosurgical correction.

Moin T, Bergsneider M, Vespa P, Heaney AP.

J Clin Endocrinol Metab. 2012 Oct;97(10):3545-9. doi: 10.1210/jc.2012-1978. Epub 2012 Jul 20.

PMID:
22821894
18.

A rationale for multidisciplinary care in treating neuroendocrine tumours.

Metz DC, Choi J, Strosberg J, Heaney AP, Howden CW, Klimstra D, Yao JC.

Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):306-13. doi: 10.1097/MED.0b013e32835570f1. Review.

PMID:
22760514
19.

Bilateral adrenalectomy: lifesaving procedure in severe Cushing syndrome.

Han JY, Mirsadraei L, Yeh MW, Suh JD, Yong WH, Bergsneider M, Heaney AP.

Endocr Pract. 2012 Jul-Aug;18(4):e85-90. doi: 10.4158/EP11315.CR.

PMID:
22441001
20.

Acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature.

Appel JG, Bergsneider M, Vinters H, Salamon N, Wang MB, Heaney AP.

Pituitary. 2012 Dec;15 Suppl 1:S53-6. doi: 10.1007/s11102-011-0345-9. Review.

PMID:
21960210
21.

Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.

Heaney AP.

J Clin Endocrinol Metab. 2011 Dec;96(12):3649-60. doi: 10.1210/jc.2011-2031. Epub 2011 Sep 28. Review. Erratum in: J Clin Endocrinol Metab. 2012 Mar;97(3):1064.

22.

Refined fructose and cancer.

Liu H, Heaney AP.

Expert Opin Ther Targets. 2011 Sep;15(9):1049-59. doi: 10.1517/14728222.2011.588208. Epub 2011 May 31. Review.

PMID:
21623683
23.

Fructose impairs glucose-induced hepatic triglyceride synthesis.

Huang D, Dhawan T, Young S, Yong WH, Boros LG, Heaney AP.

Lipids Health Dis. 2011 Jan 24;10:20. doi: 10.1186/1476-511X-10-20.

24.

Fructose induces transketolase flux to promote pancreatic cancer growth.

Liu H, Huang D, McArthur DL, Boros LG, Nissen N, Heaney AP.

Cancer Res. 2010 Aug 1;70(15):6368-76. doi: 10.1158/0008-5472.CAN-09-4615. Epub 2010 Jul 20.

25.

Direct spectrophotometric determination of serum fructose in pancreatic cancer patients.

Hui H, Huang D, McArthur D, Nissen N, Boros LG, Heaney AP.

Pancreas. 2009 Aug;38(6):706-12. doi: 10.1097/MPA.0b013e3181a7c6e5.

PMID:
19506535
26.

Medical treatment of Cushing's disease: Overview and recent findings.

Praw SS, Heaney AP.

Int J Gen Med. 2009 Dec 29;2:209-17.

27.

Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature.

Yu R, Nissen NN, Dhall D, Heaney AP.

Pancreas. 2008 May;36(4):428-31. doi: 10.1097/MPA.0b013e31815ceb23.

PMID:
18437091
28.

Targeting pituitary tumors.

Heaney AP.

Horm Res. 2007;68 Suppl 5:132-6. doi: 10.1159/000110608. Epub 2007 Dec 10. Review.

PMID:
18174730
29.

The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis.

Hui H, Fernando MA, Heaney AP.

Eur J Cancer. 2008 Jan;44(1):160-6. Epub 2007 Nov 26.

PMID:
18042375
30.

Primary hepatic carcinoid tumor presenting as Cushing's syndrome.

Shah NA, Urusova IA, D'Agnolo A, Colquhoun SD, Rosenbloom BE, Vener SL, Geller SA, Younes M, Lechago J, Heaney AP.

J Endocrinol Invest. 2007 Apr;30(4):327-33.

PMID:
17556871
31.

Temozolomide: a novel treatment for pituitary carcinoma.

Lim S, Shahinian H, Maya MM, Yong W, Heaney AP.

Lancet Oncol. 2006 Jun;7(6):518-20. No abstract available.

PMID:
16750503
32.

Pituitary tumour pathogenesis.

Heaney AP.

Br Med Bull. 2006 May 9;75-76:81-97. Print 2005. Review.

PMID:
16684928
33.

PPAR-gamma in Cushing's disease.

Heaney AP.

Pituitary. 2004;7(4):265-9. Review.

PMID:
16416039
34.

Alpha1-adrenergic receptor antagonists: novel therapy for pituitary adenomas.

Fernando MA, Heaney AP.

Mol Endocrinol. 2005 Dec;19(12):3085-96. Epub 2005 Jul 14.

PMID:
16020484
35.

Securin is overexpressed in breast cancer.

Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP.

Mod Pathol. 2005 Jul;18(7):985-90.

36.

Novel medical approaches for the treatment of Cushing's disease.

Heaney AP.

J Endocrinol Invest. 2004 Jun;27(6):591-5. Review. No abstract available.

PMID:
15717660
37.

Molecular targets in pituitary tumours.

Heaney AP, Melmed S.

Nat Rev Cancer. 2004 Apr;4(4):285-95. Review. No abstract available.

PMID:
15057288
38.

Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.

Heaney AP.

Pituitary. 2003;6(3):153-9. Review.

PMID:
14971739
39.

Pituitary tumour transforming gene in endocrine cancer.

McCabe CJ, Heaney AP.

Clin Endocrinol (Oxf). 2003 Jun;58(6):673-82. Review. No abstract available.

PMID:
12780741
40.

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.

Heaney AP, Fernando M, Melmed S.

J Clin Invest. 2003 May;111(9):1381-8.

41.

Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.

McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA, Gittoes NJ.

Clin Endocrinol (Oxf). 2003 Feb;58(2):141-50.

PMID:
12580928
42.

Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.

Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD, Melmed S.

J Clin Endocrinol Metab. 2003 Feb;88(2):858-63.

PMID:
12574225
43.

Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression.

Horwitz GA, Miklovsky I, Heaney AP, Ren SG, Melmed S.

Mol Endocrinol. 2003 Apr;17(4):600-9. Epub 2003 Jan 16.

PMID:
12554778
44.

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas.

Heaney AP, Fernando M, Yong WH, Melmed S.

Nat Med. 2002 Nov;8(11):1281-7. Epub 2002 Oct 15.

PMID:
12379847
45.

Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.

McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA, Gittoes NJ.

J Clin Endocrinol Metab. 2002 Sep;87(9):4238-44.

PMID:
12213878
46.

Functional role of estrogen in pituitary tumor pathogenesis.

Heaney AP, Fernando M, Melmed S.

J Clin Invest. 2002 Jan;109(2):277-83.

47.

Transforming events in thyroid tumorigenesis and their association with follicular lesions.

Heaney AP, Nelson V, Fernando M, Horwitz G.

J Clin Endocrinol Metab. 2001 Oct;86(10):5025-32.

PMID:
11600580
48.

Human pituitary tumor-transforming gene induces angiogenesis.

Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S.

J Clin Endocrinol Metab. 2001 Feb;86(2):867-74.

PMID:
11158059
49.

Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.

Heaney AP, Curry WJ, Pogue KM, Armstrong VL, Mirakhur M, Sheridan B, Johnston CF, Buchanan KD, Atkinson AB.

Pituitary. 2000 Oct;3(2):67-75.

PMID:
11141698
50.

Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis.

Yu R, Heaney AP, Lu W, Chen J, Melmed S.

J Biol Chem. 2000 Nov 24;275(47):36502-5.

Supplemental Content

Loading ...
Support Center